BVF Inc’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-1,484,674
Closed -$88.8M – 65
2020
Q2
$88.8M Sell
1,484,674
-98,921
-6% -$6.11M 5.47% 2
2020
Q1
$94M Sell
1,583,595
-133,139
-8% -$7.76M 8.76% 1
2019
Q4
$94M Buy
+1,716,734
New +$64.1M 7.13% 4
2019
Q1
– Sell
-146,300
Closed -$4.01M – 56
2018
Q4
$4.01M Sell
146,300
-93,700
-39% -$2.41M 0.52% 42
2018
Q3
$7.01M Buy
+240,000
New +$6.77M 0.62% 42

Other funds holding PRNB

BVF Inc's PRNB Position: Q3 2020 in Review

BVF Inc sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 1,484,674 shares — an estimated $88.8M sold.

BVF Inc first reported a position in PRNB in Q3 2018 and held it in 5 quarters. The position peaked at $94M in Q4 2019. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • BVF Inc reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • BVF Inc sold 1,484,674 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $88.8M.
  • BVF Inc first reported a position in Principia Biopharma Inc. Common Stock in Q3 2018 and held it in 5 quarters.
  • BVF Inc's Principia Biopharma Inc. Common Stock position peaked at $94M in Q4 2019.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on BVF Inc's 13F filing for Q3 2020, filed 13 Nov 2020.